(NUVB) Nuvation Bio - Performance -38% in 12m
Compare NUVB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-78.78%
#129 in Group
Rel. Strength
23.40%
#6095 in Universe
Total Return 12m
-37.98%
#71 in Group
Total Return 5y
-79.10%
#86 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -56.84%
(?) Percentile in Group
12m Total Return: NUVB (-38%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: NUVB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NUVB
Total Return (including Dividends) | NUVB | XBI | S&P 500 |
---|---|---|---|
1 Month | 5.03% | 2.77% | 5.69% |
3 Months | -6.28% | -14.21% | -6.49% |
12 Months | -37.98% | -14.88% | 9.72% |
5 Years | -79.10% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | NUVB | XBI | S&P 500 |
1 Month | 68.2% | 57% | 89.4% |
3 Months | -10.7% | -82.3% | -72% |
12 Months | -81.7% | -53.1% | 49.3% |
5 Years | -72.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #13 | 2.19% | -0.63% |
3 Month | #37 | 9.25% | 0.22% |
12 Month | #70 | -27.1% | -43.5% |
5 Years | #83 | -70.4% | -88.1% |
FAQs
Does NUVB Nuvation Bio outperforms the market?
No,
over the last 12 months NUVB made -37.98%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months NUVB made -6.28%, while XBI made -14.21%.
Over the last 3 months NUVB made -6.28%, while XBI made -14.21%.
Performance Comparison NUVB vs Indeces and Sectors
NUVB vs. Indices NUVB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -12.3% | -0.66% | -25.4% | -47.7% |
US NASDAQ 100 | QQQ | -12.6% | -2.36% | -25.8% | -48.8% |
US Dow Jones Industrial 30 | DIA | -12.2% | 2.36% | -24.4% | -44.2% |
German DAX 40 | DAX | -12.8% | -10.0% | -51.0% | -62.8% |
Shanghai Shenzhen CSI 300 | CSI 300 | -12.6% | 2.15% | -24.6% | -44.3% |
Hongkong Hang Seng | HSI | -15.2% | -9.87% | -34.9% | -46.2% |
India NIFTY 50 | INDA | -8.63% | 1.82% | -27.3% | -40.0% |
Brasil Bovespa | EWZ | -15.4% | -6.59% | -34.6% | -31.7% |
NUVB vs. Sectors NUVB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -11.7% | -1.45% | -31.6% | -58.4% |
Consumer Discretionary | XLY | -13.8% | -1.66% | -23.2% | -52.8% |
Consumer Staples | XLP | -11.5% | 4.33% | -32.3% | -45.2% |
Energy | XLE | -14.6% | 0.54% | -19.4% | -29.0% |
Financial | XLF | -13.0% | -1.81% | -31.3% | -59.5% |
Health Care | XLV | -8.23% | 8.09% | -20.2% | -32.0% |
Industrial | XLI | -13.3% | -3.28% | -26.4% | -48.4% |
Materials | XLB | -12.5% | -0.01% | -21.4% | -31.9% |
Real Estate | XLRE | -11.5% | -1.88% | -27.8% | -51.6% |
Technology | XLK | -13.2% | -4.68% | -23.1% | -44.1% |
Utilities | XLU | -13.1% | -0.11% | -33.2% | -54.0% |
Aerospace & Defense | XAR | -12.5% | -4.14% | -34.7% | -63.9% |
Biotech | XBI | -4.61% | 2.26% | -4.35% | -23.1% |
Homebuilder | XHB | -12.0% | -0.58% | -11.8% | -29.1% |
Retail | XRT | -12.4% | -1.11% | -19.1% | -31.7% |